QNTM Form 6-K: Report of foreign private issuer

Quantum BioPharma Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

2026-09-24: Form 6-K; Period of report 2026-09-24; Description FORM 6-K; Document f6k_092426.htm.
2026-09-17: Form 6-K; Period of report 2026-09-17; Description FORM 6-K; Document qntm6k091726.htm.
2026-09-17: Form 6-K; Period of report 2026-09-17; Description FORM 6-K; Document f6k_091726.htm.
2026-09-15: Form 6-K; Period of report 2026-09-15; Description FORM 6-K; Document f6k_091426.htm.

Filed	Form	Period of report	Description	Document
2026-09-24	6-K	2026-09-24	FORM 6-K	f6k_092426.htm
2026-09-17	6-K	2026-09-17	FORM 6-K	qntm6k091726.htm
2026-09-17	6-K	2026-09-17	FORM 6-K	f6k_091726.htm
2026-09-15	6-K	2026-09-15	FORM 6-K	f6k_091426.htm
2026-09-08	6-K/A	2026-09-08	FORM 6-K/A	qntm6ka090826.htm
2026-09-08	6-K/A	2026-09-08	FORM 6-K/A	qntm6ka090826.htm
2026-09-08	6-K/A	2026-09-08	FORM 6-K/A	qntm6ka090826.htm
2026-09-02	6-K	2026-09-01	FORM 6-K	qntm6k090126.htm
2026-08-14	6-K	2026-08-14	FORM 6-K	f6k_081426.htm
2026-08-13	6-K	2026-06-30	FORM 6-K	qntm6k080726.htm
2026-08-13	6-K/A	2026-08-13	FORM 6-K/A	qntm6ka081326.htm
2026-08-10	6-K	2026-08-10	FORM 6-K	f6k_081026.htm
2026-06-02	6-K	2026-06-02	FORM 6-K	qntm6k060226.htm
2026-06-02	6-K	2026-06-02	FORM 6-K	f6k_060226.htm
2026-05-18	6-K	2026-05-18	FORM 6-K	f6k_051826.htm
2026-05-07	6-K	2026-05-07	FORM 6-K	f6k_050726.htm
2026-05-06	6-K	2026-03-31	FORM 6-K	qntm6k050426.htm
2026-04-22	6-K	2026-04-22	FORM 6-K	f6k_042226.htm
2026-04-02	6-K	2026-04-02	FORM 6-K	f6k_040126.htm
2026-04-01	6-K	2026-04-01	FORM 6-K	f6k_033126.htm
2026-03-30	6-K	2026-03-30	FORM 6-K	f6k_033026.htm
2026-03-27	6-K	2026-03-27	FORM 6-K	f6k_032626.htm
2026-03-26	6-K	2026-03-26	FORM 6-K	f6k_032626.htm
2026-03-23	6-K	2026-03-23	FORM 6-K	f6k_032326.htm